Daniel I. Swerdlow
Silence Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Bioinformatics and Genomic Networks, Cancer, Lipids, and Metabolism
Most-Cited Works
- → The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis(2012)1,135 cited
- → Mendelian randomization of blood lipids for coronary heart disease(2014)781 cited
- → HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials(2014)704 cited
- → Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data(2014)671 cited
- → Selecting instruments for Mendelian randomization in the wake of genome-wide association studies(2016)424 cited
- → PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study(2016)384 cited
- → Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes(2016)314 cited
- → Mendelian randomization for studying the effects of perturbing drug targets(2021)278 cited
- → Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels(2022)274 cited
- → Large-Scale Gene-Centric Meta-analysis across 32 Studies Identifies Multiple Lipid Loci(2012)268 cited